BACKGROUND: The effects of novel biocompatible peritoneal dialysis (PD) solutions on human peritoneal membrane pathology have yet to be determined. Quantitative evaluation of human peritoneal biopsy specimens may reveal the effects of the new solutions on peritoneal membrane pathology. ♢ METHODS: Peritoneal specimens from 24 PD patients being treated with either acidic solution containing high-glucose degradation products [GDPs (n = 12)] or neutral solution with low GDPs (n = 12) were investigated at the end of PD. As controls, pre-PD peritoneal specimens, obtained from 13 patients at PD catheter insertion, were also investigated. The extent of peritoneal fibrosis, vascular sclerosis, and advanced glycation end-product (AGE) accumulation were evaluated by quantitative or semi-quantitative methods. The average densities of CD31-positive vessels and podoplanin-positive lymphatic vessels were also determined. ♢ RESULTS: Peritoneal membrane fibrosis, vascular sclerosis, and AGE accumulation were significantly suppressed in the neutral group compared with the acidic group. The neutral group also showed lower peritoneal equilibration test scores and preserved ultrafiltration volume. The density of blood capillaries, but not of lymphatic capillaries, was significantly increased in the neutral group compared with the acidic and pre-PD groups. ♢ CONCLUSIONS: Neutral solutions with low GDPs are associated with less peritoneal membrane fibrosis and vascular sclerosis through suppression of AGE accumulation. However, contrary to expectation, blood capillary density was increased in the neutral group. The altered contents of the new PD solutions modified peritoneal membrane morphology and function in patients undergoing PD.
BACKGROUND: The effects of novel biocompatible peritoneal dialysis (PD) solutions on human peritoneal membrane pathology have yet to be determined. Quantitative evaluation of human peritoneal biopsy specimens may reveal the effects of the new solutions on peritoneal membrane pathology. ♢ METHODS: Peritoneal specimens from 24 PDpatients being treated with either acidic solution containing high-glucose degradation products [GDPs (n = 12)] or neutral solution with low GDPs (n = 12) were investigated at the end of PD. As controls, pre-PD peritoneal specimens, obtained from 13 patients at PD catheter insertion, were also investigated. The extent of peritoneal fibrosis, vascular sclerosis, and advanced glycation end-product (AGE) accumulation were evaluated by quantitative or semi-quantitative methods. The average densities of CD31-positive vessels and podoplanin-positive lymphatic vessels were also determined. ♢ RESULTS: Peritoneal membrane fibrosis, vascular sclerosis, and AGE accumulation were significantly suppressed in the neutral group compared with the acidic group. The neutral group also showed lower peritoneal equilibration test scores and preserved ultrafiltration volume. The density of blood capillaries, but not of lymphatic capillaries, was significantly increased in the neutral group compared with the acidic and pre-PD groups. ♢ CONCLUSIONS: Neutral solutions with low GDPs are associated with less peritoneal membrane fibrosis and vascular sclerosis through suppression of AGE accumulation. However, contrary to expectation, blood capillary density was increased in the neutral group. The altered contents of the new PD solutions modified peritoneal membrane morphology and function in patients undergoing PD.
Authors: Luiz S Aroeira; Abelardo Aguilera; Rafael Selgas; Marta Ramírez-Huesca; M Luisa Pérez-Lozano; Antonio Cirugeda; M Auxiliadora Bajo; Gloria del Peso; José A Sánchez-Tomero; José A Jiménez-Heffernan; Manuel López-Cabrera Journal: Am J Kidney Dis Date: 2005-11 Impact factor: 8.860
Authors: K Honda; K Nitta; S Horita; W Yumura; H Nihei; R Nagai; K Ikeda; S Horiuchi Journal: Nephrol Dial Transplant Date: 1999-06 Impact factor: 5.992
Authors: S Jones; C J Holmes; R T Krediet; R Mackenzie; D Faict; A Tranaeus; J D Williams; G A Coles; N Topley Journal: Kidney Int Date: 2001-04 Impact factor: 10.612
Authors: Gloria del Peso; José Antonio Jiménez-Heffernan; Rafael Selgas; César Remón; Marta Ossorio; Antonio Fernández-Perpén; José Antonio Sánchez-Tomero; Antonio Cirugeda; Erika de Sousa; Pilar Sandoval; Raquel Díaz; Manuel López-Cabrera; María Auxiliadora Bajo Journal: Perit Dial Int Date: 2015-10-16 Impact factor: 1.756
Authors: Monika Lichodziejewska-Niemierko; Michał Chmielewski; Maria Dudziak; Alicja Ryta; Bolesław Rutkowski Journal: Perit Dial Int Date: 2015-10-16 Impact factor: 1.756
Authors: Sarah E Herlihy; Hannah E Starke; Melisa Lopez-Anton; Nehemiah Cox; Katayoon Keyhanian; Donald J Fraser; Richard H Gomer Journal: Perit Dial Int Date: 2015-10-22 Impact factor: 1.756
Authors: Carmen A Vlahu; Jan Aten; Marijke de Graaff; Henk van Veen; Vincent Everts; Dirk R de Waart; Dirk G Struijk; Raymond T Krediet Journal: Perit Dial Int Date: 2016-05-04 Impact factor: 1.756